Cardiff Oncology Inc. buy BiotechBee
Start price
29.04.24
/
50%
€4.28
Target price
31.07.26
€5.00
Performance (%)
-51.11%
End price
08.09.24
€2.09
Summary
This prediction ended on 08.09.24 with a price of €2.09. Massive losses of -51.11% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cardiff Oncology Inc. | -5.847% | -5.847% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
According to BiotechBee what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Trovagene diskutieren
Buy mit Kursziel 5,0
In the thread Trading Trovagene
Buy beendet